Language: English
Published by LAP LAMBERT Academic Publishing, 2018
ISBN 10: 6139875390 ISBN 13: 9786139875399
Seller: Revaluation Books, Exeter, United Kingdom
US$ 118.13
Quantity: 1 available
Add to basketPaperback. Condition: Brand New. 128 pages. 8.66x5.91x0.29 inches. In Stock.
Language: English
Published by LAP LAMBERT Academic Publishing Aug 2018, 2018
ISBN 10: 6139875390 ISBN 13: 9786139875399
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Regadenoson is a drug which is presently in the form of IV to increase blood flow in arteries of heart. IV is a painful route of administration and also require skill person to administer. Hence in this study sublingual tablet is prepared by using different excipients which help in immediate release of tablet and also it directly goes in blood stream by bypassing the liver enzymes. QbD approach was used to build the quality in product and also throughout the process. Design Expert software was used to evaluate various parameters. This study was carried out by using factorial design using 2 independent variables and 3 levels to optimize the formulation. -Ms.Khan Samreen Fatima 128 pp. Englisch.
Language: English
Published by LAP LAMBERT Academic Publishing, 2018
ISBN 10: 6139875390 ISBN 13: 9786139875399
Seller: moluna, Greven, Germany
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Fatima Khan SamreenMs. Khan Samreen fatima. Master of pharmacy (Quality Assurance) from YB chavan college of pharmacy, Aurangabad. Maharashtra.Regadenoson is a drug which is presently in the form of IV to increase blood flow in a.
Language: English
Published by LAP LAMBERT Academic Publishing, 2018
ISBN 10: 6139875390 ISBN 13: 9786139875399
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Regadenoson is a drug which is presently in the form of IV to increase blood flow in arteries of heart. IV is a painful route of administration and also require skill person to administer. Hence in this study sublingual tablet is prepared by using different excipients which help in immediate release of tablet and also it directly goes in blood stream by bypassing the liver enzymes. QbD approach was used to build the quality in product and also throughout the process. Design Expert software was used to evaluate various parameters. This study was carried out by using factorial design using 2 independent variables and 3 levels to optimize the formulation. -Ms.Khan Samreen Fatima.
Language: English
Published by LAP LAMBERT Academic Publishing Aug 2018, 2018
ISBN 10: 6139875390 ISBN 13: 9786139875399
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Regadenoson is a drug which is presently in the form of IV to increase blood flow in arteries of heart. IV is a painful route of administration and also require skill person to administer. Hence in this study sublingual tablet is prepared by using different excipients which help in immediate release of tablet and also it directly goes in blood stream by bypassing the liver enzymes. QbD approach was used to build the quality in product and also throughout the process. Design Expert software was used to evaluate various parameters. This study was carried out by using factorial design using 2 independent variables and 3 levels to optimize the formulation. -Ms.Khan Samreen FatimaVDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 128 pp. Englisch.
Language: English
Published by LAP LAMBERT Academic Publishing, 2018
ISBN 10: 6139875390 ISBN 13: 9786139875399
Seller: preigu, Osnabrück, Germany
Taschenbuch. Condition: Neu. Formulation and evaluation of sublingual tablet of Regadenoson by QbD | Khan Samreen Fatima (u. a.) | Taschenbuch | 128 S. | Englisch | 2018 | LAP LAMBERT Academic Publishing | EAN 9786139875399 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand.